Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment
Clinical trial NCT04085276 · COMPLETED
Trial details
- NCT number
- NCT04085276
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-21
- Primary completion
- 2024-12-31
- Enrollment
- 531
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.